InvestorsHub Logo
Followers 11
Posts 601
Boards Moderated 0
Alias Born 04/16/2015

Re: None

Monday, 03/21/2016 10:04:39 PM

Monday, March 21, 2016 10:04:39 PM

Post# of 73041
"ViaDerma, Inc. is a specialty pharmaceutical company committed to bringing new products to market through innovative research & development. ViaDerma licenses products in fields of medicine ranging from infectious diseases to wound care."

Check out the potential markets they can hit

"ViaDerma is developing products in many fields of use, including:
Topical antibiotics- $6 billion/year
Toenail antifungal drugs- $3 billion/year
Diabetic amputations- $3 billion/year
Global acne- $2.8 million in 2009, estimates of $3.02 billion by 2016
Psoriasis- $2.4 billion in 2010, estimates of over $7.3 billion by 2015
Eczema- $2.5 billion in 2014"

We are talking billions! One little deal, and we are off to the races! Tell me another stock in the OTC with this share structure that includes a real product!

$VDRM is the real deal guys. Good luck to all investors who are joining us on this ride! Check out the website and do you DD and you'll all see what the hype is about www.viadermalicensing.com